Bill has a chemistry background with over 25 years in the pharmaceutical and biotechnology industries at Bristol-Myers Squibb and Amgen.  He led Discovery Technologies at Amgen running multidisciplinary teams over 4 research sites and shared chemistry technical oversight of 9 INDs in oncology, inflammation, neuroscience, and diabetes.